NCT01043965View on ClinicalTrials.gov

Myocardial Perfusion in Type 2 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin

Metformin 850mg

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo General Hospital

OTHER

NCT01043965 - Myocardial Perfusion in Type 2 Diabetes | Biotech Hunter | Biotech Hunter